32453-59-1

Basic information

• Product Name: (2R,3S,4R,5R)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate
• Synonyms: (2R,3S,4R,5R)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate
• CAS NO: 32453-59-1
• Molecular Weight: 290.27
• Mol File: 32453-59-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (2R,3S,4R,5R)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S,4R,5R)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate(32453-59-1)
• EPA Substance Registry System: (2R,3S,4R,5R)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate(32453-59-1)

Safety Data

• Hazardous Substances Data: 32453-59-1(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 53448-52-5 methyl β-L-xylopyranoside 
• 612-05-5 methyl-β-D-xylopyranoside 
• 91-09-8 methyl α,β-L-xyloside 
• 91-09-8 methyl α-L-xylopyranoside 
• 95851-48-2 C₄₂H₆₈O₁₂ 
• 19186-38-0 O¹,O³,O⁴-Triacetyl-α-D-xylopyranose 
• 74-88-4 methyl iodide 
• 32453-58-0 methyl-2,3,4-tri-O-acetyl-6-deoxy-β-L-glucopyranoside 
• 67-56-1 methanol 
• 532-20-7 D-arabinofuranose 
• 4049-33-6 tetra-O-acetyl-β-D-xylopyranose 

Downstream Products

• 34168-73-5 1,2,3,4,5-penta-O-acetyl-aldehydo-D-arabinose, methyl semiacetal 
• 32453-58-0 methyl-2,3,4-tri-O-acetyl-6-deoxy-β-L-glucopyranoside 
• 19186-37-9 1,2,3,4-tetra-O-acetyl-α-D-arabinopyranose 
• 25243-38-3 1,2,3,4-tetra-O-acetyl-β-D-arabinopyranose 
• 13035-61-5 1,2,3,5-tetra-O-acetyl-α-D-arabinofuranose 
• 17296-22-9 1,1,2,3,4,5-hexa-O-acetyl-aldehydo-D-arabinose 
• 612-05-5 methyl-β-D-xylopyranoside 
• 74162-08-6 methyl 2,4-di-O-acetyl-β-D-xylopyranoside 
• 41897-35-2 methyl 2-mono-O-acetyl-β-D-xylopyranoside 
• 77217-82-4 methyl 3,4-di-O-acetyl-β-D-xylopyranoside 
• 4594-60-9 methyl 3,4-O-isopropylidene-β-D-arabinopyranoside 
• 5328-63-2 methyl-β-D-arabinopyranoside 

Relevant articles and documents

ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE

Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.

Synthesis of acylated methyl β-D-xylopyranosides and their enzymic deacylations by rabbit serum esterases

Selective pivaloylations of methyl β-D-xylopyranoside have been studied under various reaction conditions. Partially pivaloylated products were submitted to additional acetylations. The structures were established by 1H NMR spectroscopy. Representatives of acylated methyl β-D-xylopyranosides (acyl being pivaloyl, acetyl, or a combination of both) were submitted to hydrolysis catalyzed by rabbit serum and esterases isolated from rabbit serum.

Studies on the constituents of Momordica cochinchinensis SPRENG. II. Isolation and characterization of the root saponins, momordins I, II and III

-